
SC1
CAS No. 839707-37-8
SC1( Pluripotin )
Catalog No. M16118 CAS No. 839707-37-8
Pluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 39 | In Stock |
![]() ![]() |
5MG | 55 | In Stock |
![]() ![]() |
10MG | 77 | In Stock |
![]() ![]() |
25MG | 135 | In Stock |
![]() ![]() |
50MG | 208 | In Stock |
![]() ![]() |
100MG | 332 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSC1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
-
DescriptionPluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.(In Vitro):Pluripotin (SC-1) inhibits Abl1, p70S6K, PLK2, RSK1, RSK2, RSK3, RSK4 with IC50s of 0.005, 1.4, 2.2, 0.5, 2.5, 3.3, 10.0 μM,respectively. Pluripotin (SC-1) decreases cell growth for 7 colon tumor cell lines. After a five day exposure to 0.1 μM SC-1, the seven colon tumor lines are evaluated for changes in cell number and viability. There is a statistically significant decrease in cell number but >95% viability.
-
In VitroPluripotin (SC-1) inhibits Abl1, p70S6K, PLK2, RSK1, RSK2, RSK3, RSK4 with IC50s of 0.005, 1.4, 2.2, 0.5, 2.5, 3.3, 10.0 μM,respectively. Pluripotin (SC-1) decreases cell growth for 7 colon tumor cell lines. After a five day exposure to 0.1 μM SC-1, the seven colon tumor lines are evaluated for changes in cell number and viability. There is a statistically significant decrease in cell number but >95% viability.
-
In Vivo——
-
SynonymsPluripotin
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK1| RasGAP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number839707-37-8
-
Formula Weight550.53
-
Molecular FormulaC27H25F3N8O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: <1 mg/mL; DMSO: 100 mg/mL (181.64 mM) Water: <1 mg/mL
-
SMILESO=C(NC1=CC=C(C)C(N2CC3=CN=C(NC4=CC(C)=NN4C)N=C3N(C)C2=O)=C1)C5=CC=CC(C(F)(F)F)=C5
-
Chemical NameN-[3-[7-(2,5-Dimethyl-2H-pyrazol-3-ylamino)-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl]-4-methylphenyl]-3-trifluoromethyl-benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen S, et al. Proc natl Acad Sci U S A. 2006 Nov 14;103(46):17266-71.
molnova catalog



related products
-
ERK5-IN-2
ERK5-IN-2 is an orally active sub-micromolar selective ERK5 inhibitor with IC50s of 0.82 μM 3 μM for ERK5 and ERK5 MEF2D respectively.
-
AZ6197
AZ6197 (AZ-6197) is a potent, selective, reversible inhibitor of ERK1/2 with IC50 of <0.3 nM (ERK2).
-
MK-8353
MK-8353 (SCH-900353) is a?highly potent, orally bioavailable, dual-specificity ERK1/2 inhibitor with IC50 of 23.0/8.8 nM, respectively.